Trend of surgical multimodality treatment for advanced gastric cancer
- Author:
- No author available
- Journal Title:
- Chinese Journal of Gastrointestinal Surgery
- Issue:
- 2
- DOI:
- 10.3760/cma.j.issn.1671-0274.2012.02.001
- Key Word:
- 胃肿瘤,进展期;外科手术;综合治疗;Stomach neoplasms,advanced;Surgical procedures;Multimodal therapy
Abstract： Gastric cancer remains one of the most common causes of cancer-related death in China.Radical operation is the only potentially curative therapy for advanced gastric cancer(AGC).D2 radical gastrectomy has been widely accepted as a standard surgical procedure for patients with AGC in China.Several clinical trials have revealed that more extended resection than D2 surgery has no impact on survival.In order to improve the prognosis of AGC patients, it is necessary to carry out the preoperative TNM staging for selecting a reasonable therapeutical modality before surgery.Multimodality treatment involving perioperative chemotherapy,radiotherapy or molecular targeting agents in addition to surgery have been thought to be promising treatment strategy.In this article,we present an update on the current literature regarding the trends of surgical multimodal treatment for the patients with AGC.
- [1]郭磊,于颖彦,朱正纲.基因芯片数据挖掘与肿瘤分子分型研究[J].2010,(1).
- [2]严超,朱正纲,燕敏,等.多排CT对胃癌腹膜转移术前预测的单中心大宗病例研究[J].2010,(2).
- [3]曾益新,邵建永.肿瘤的分子分型与分子靶向治疗[J].2008,(1).
- [4]Bang YJ,Van Cutsem E,Feyereislova A,etc.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.[J].2010,376(9742).
- [5]Paoletti X,Oba K,Michiels S,etc.Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.[J].2010,303(17).
- [6]Chen MM,Liu BY,Yin HR,etc.Value of multidetector-row computed tomography in the preoperative T and N staging of gastric carcinoma: a large-scale Chinese study.[J].2009,100(3).
- [7]Deng J,Liang H,Sun D,etc.Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China.[J].2010,17(5).
- [8]Donohue JH,Okawara GS,Ajani JA,etc.Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.[J].2006,24(24).
- [9]Yu Jo, Chua,David, Cunningham.The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice.[J].2007,14(10).
- [10]Sasako M,Sano T,Yamamoto S,etc.D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.[J].2008,359(5).
- [11]Sawa T,Bandou E,Yonemura Y,etc.Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer.[J].2008,13(2).
- [12]Spiliotis J,Zoras O.Adjuvant S-1 chemotherapy for gastric cancer and peritoneal wash.[J].2011,35(2).
- [13]Moehler M,Schmidberger H,Junginger T,etc.Multimodal treatment of gastric cancer.[J].2007,21(6).